BIGBEAR
PHARMACEUTICAL
Pralsetinib inhibits the abnormal activation of RET protein and blocks downstream signaling pathways.
AuthenticGuaranteeFast DeliveryPrivacy The price of Pralsetinib varies depending on the region, medical insurance policies, and drug specifications. In the domestic market, the price is typ···【More】
Update: 24 Mar,2026Source: BigbearViews: 103
The price of pralatinib varies depending on the strength, region, and purchase channel, typically ranging from 30,000 to 50,000 yuan per box. The spec···【More】
Update: 24 Mar,2026Source: BigbearViews: 106
The price of pralatinib varies significantly depending on the drug version, strength, whether it is covered by medical insurance, and the purchase cha···【More】
Update: 24 Mar,2026Source: BigbearViews: 111
Ponatinib is an oral tyrosine kinase inhibitor whose main component is ponatinib hydrochloride. It is indicated for the treatment of hematologic malig···【More】
Update: 16 Mar,2026Source: BigbearViews: 101
Ponatinib is an oral tyrosine kinase inhibitor available in tablet form. It is indicated for the treatment of hematologic malignancies such as Philade···【More】
Update: 16 Mar,2026Source: BigbearViews: 112
Pratinib is an oral tyrosine kinase inhibitor that, through its precise targeted mechanism of action, provides an important treatment option for adult···【More】
Update: 16 Mar,2026Source: BigbearViews: 108
Pratinib is an oral tyrosine kinase inhibitor available in capsule form. It is primarily used for the treatment of adult patients with rearranged duri···【More】
Update: 16 Mar,2026Source: BigbearViews: 114
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
